can i take tirzepatide while breastfeeding You Breastfeeding? Safety Information Early evidence by InfantRisk Center

Your provider may also gradually increase your dose over time to keep side effects minimal

In normoglycemic, non-obese rabbits , liraglutide significantly inhibited atherosclerosis progression, with meaningful reductions in percent atheroma volume, plaque macrophage content, cathepsin activity, and systemic CRP

(Source: Long-term GLP-1 safety review, June 2026) There Is No Evidence Supporting a Hard Time Limit on Treatment A frequent patient concern is that GLP-1s cannot be safe indefinitely

Emerg Med J 25:3337 Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, Duplancic B, Uzun S, Zivanovic-Posilovic G, Kolenc D, Drmic D (2016) BPC 157: the counteraction of succinylcholine, hyperkalemia, and arrhythmias

Acute administration of GLP-1a in humans has been shown to no effects and sometimes increased BP in humans

[Abstract] Acta Pharm Sin B